Marked bilateral ankle swelling, associated with a petechial non-blanching rash and areas of erythema in a patient on treatment with nifedipine tablets (Adalat Retard). 
Discussion
Non-pitting peripheral oedema is one of the most commonly described adverse effects of calcium channel blocking drugs. It has been described with all the available dihydropyridine agents and may occur with diltiazem. An early study suggested that the incidence of oedema with nifedipine was 11.6% in those treated for 6 months or longer. 1 In the more recent MATH 2 and EXACT 3 trials, involving nifedipine in the extended-release formulation (Adalat XL) for treatment of hypertension, the incidence of oedema was 7.7% and 8.1% in those treated for over 18 and 20 weeks respectively. With amlodipine, an early analysis of pooled data on 581 treated patients found that the incidence of oedema was 11.6% in younger patients and 16.4% in older patients. 4 Prescription-Event Monitoring (PEM), a national scheme for postmarketing surveillance, has reported that the incidence of peripheral oedema was less with diltiazem than with amlodipine use. 5 The peripheral oedema caused by calcium channel blockers is dose dependent 3 and is increased by prolonged dependency. The oedema is caused by the inhibition of the pre-capillary reflex 6 on standing upright, which increases the hydrostatic pressure on the arteriolar side of the capillary bed leading to an increase in capillary filtration pressure. The oedema is not associated with salt and water retention, indeed the dihydropyridines are natriuretic, and does not improve with diuretic therapy. 7 Mild oedema which is not troublesome to the patient does not require specific treatment and may improve with time. In more severe cases, dose reduction or drug withdrawal may be necessary. 8 If continued use of the drug is necessary, for example because of intolerance of other classes of antihypertensive, problematic oedema may also be helped by simple measures such as elevation of the legs when seated or lying flat and by wearing graduated compression stockings.
A much less recognised but in our experience a common associated feature is lower limb petechial, non-blanching rash. This is believed to result from leakage of red blood cells from capillaries into the interstitium and can cause a long lasting discolouration. Our experience, as in this patient, is that withdrawal of drug results eventually in resolution of the rash.
